Shares of TherapeuticsMD (TXMD) dropped 7.91% to $1.28 at 11:23 EST on Thursday, after three consecutive sessions in a row of gains. NASDAQ Composite (TXMD) is jumping 0.18% to $13,936.92, following the last session’s downward trend, This seems, as yet, a somewhat bullish trend exchanging session today.
TherapeuticsMD’s last close was $1.39, 49.45% under its 52-week high of $2.75.
Today’s last reported volume for TherapeuticsMD is 3477387 which is 60.54% below its average volume of 8813053.
The company’s growth estimates for the current quarter and the next is 47.4% and 25%, respectively.
Year-on-year quarterly revenue growth grew by 42%, now sitting on 64.87M for the twelve trailing months.
TherapeuticsMD’s last week, last month’s, and last quarter’s current volatility was 0.27%, 0.70%, and 3.84%, respectively.
TherapeuticsMD’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 2.47% (last week), 2.92% (last month), and 3.84% (last quarter), respectively.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,
TherapeuticsMD’s stock is considered to be oversold (<=20).
TherapeuticsMD’s Stock Yearly Top and Bottom Value
TherapeuticsMD’s stock is valued at $1.28 at 11:23 EST, way below its 52-week high of $2.75 and way above its 52-week low of $1.00.
TherapeuticsMD’s Moving Average
TherapeuticsMD’s value is higher than its 50-day moving average of $1.17 and below its 200-day moving average of $1.37.
More news about TherapeuticsMD (TXMD).